Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2246 | 2308 | 47.7 | 92% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
373 | 3 | ENDOGENOUS RETROVIRUS//VIROLOGY//JOURNAL OF VIROLOGY | 32972 |
636 | 2 | ENDOGENOUS RETROVIRUS//RETROVIRUS//RETROVIRAL VECTOR | 13733 |
2246 | 1 | LENTIVIRAL VECTOR//EXPT HEMATOL//RETROVIRAL VECTOR | 2308 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LENTIVIRAL VECTOR | authKW | 863884 | 11% | 26% | 252 |
2 | EXPT HEMATOL | address | 271125 | 8% | 11% | 183 |
3 | RETROVIRAL VECTOR | authKW | 247444 | 5% | 15% | 126 |
4 | HUMAN GENE THERAPY | journal | 215424 | 10% | 7% | 233 |
5 | MOLECULAR THERAPY | journal | 200926 | 10% | 7% | 232 |
6 | GENE THERAPY | authKW | 166408 | 18% | 3% | 426 |
7 | MOL HEMATOPOIESIS SECT | address | 144037 | 1% | 78% | 14 |
8 | LENTIVIRUS | authKW | 134688 | 5% | 8% | 120 |
9 | SELECTIVE AMPLIFIER GENE | authKW | 119056 | 0% | 100% | 9 |
10 | IMMUNODEFICIENCY | address | 110082 | 1% | 26% | 32 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Medicine, Research & Experimental | 36756 | 47% | 0% | 1082 |
2 | Biotechnology & Applied Microbiology | 23572 | 43% | 0% | 988 |
3 | Genetics & Heredity | 19872 | 39% | 0% | 894 |
4 | Hematology | 12958 | 23% | 0% | 536 |
5 | Virology | 2564 | 8% | 0% | 195 |
6 | Cell & Tissue Engineering | 1759 | 3% | 0% | 61 |
7 | Biochemistry & Molecular Biology | 448 | 16% | 0% | 366 |
8 | Oncology | 242 | 7% | 0% | 172 |
9 | Cell Biology | 231 | 7% | 0% | 166 |
10 | Transplantation | 135 | 2% | 0% | 46 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EXPT HEMATOL | 271125 | 8% | 11% | 183 |
2 | MOL HEMATOPOIESIS SECT | 144037 | 1% | 78% | 14 |
3 | IMMUNODEFICIENCY | 110082 | 1% | 26% | 32 |
4 | MOL CLIN HEMATOL BRANCH | 109085 | 1% | 25% | 33 |
5 | HEMATOL BRANCH | 106929 | 4% | 9% | 87 |
6 | U962 | 101753 | 0% | 77% | 10 |
7 | CELL VIRUS GENET | 99198 | 1% | 50% | 15 |
8 | IMMUNOL BONE MARROW TRANSPLANTAT | 85683 | 1% | 20% | 32 |
9 | CEA IMETI | 72018 | 0% | 78% | 7 |
10 | MOL IMMUNOL UNIT | 71768 | 2% | 10% | 57 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HUMAN GENE THERAPY | 215424 | 10% | 7% | 233 |
2 | MOLECULAR THERAPY | 200926 | 10% | 7% | 232 |
3 | GENE THERAPY | 105818 | 8% | 5% | 177 |
4 | JOURNAL OF GENE MEDICINE | 48707 | 3% | 5% | 72 |
5 | HUMAN GENE THERAPY METHODS | 35106 | 1% | 13% | 21 |
6 | CURRENT GENE THERAPY | 26226 | 1% | 6% | 33 |
7 | MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT | 23517 | 1% | 10% | 18 |
8 | BLOOD | 21125 | 10% | 1% | 235 |
9 | HEMATOPOIETIC STEM CELLS | 8259 | 0% | 13% | 5 |
10 | HUMAN GENE THERAPY CLINICAL DEVELOPMENT | 7990 | 0% | 9% | 7 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LENTIVIRAL VECTOR | 863884 | 11% | 26% | 252 | Search LENTIVIRAL+VECTOR | Search LENTIVIRAL+VECTOR |
2 | RETROVIRAL VECTOR | 247444 | 5% | 15% | 126 | Search RETROVIRAL+VECTOR | Search RETROVIRAL+VECTOR |
3 | GENE THERAPY | 166408 | 18% | 3% | 426 | Search GENE+THERAPY | Search GENE+THERAPY |
4 | LENTIVIRUS | 134688 | 5% | 8% | 120 | Search LENTIVIRUS | Search LENTIVIRUS |
5 | SELECTIVE AMPLIFIER GENE | 119056 | 0% | 100% | 9 | Search SELECTIVE+AMPLIFIER+GENE | Search SELECTIVE+AMPLIFIER+GENE |
6 | HEMATOPOIETIC STEM CELLS | 102441 | 6% | 6% | 134 | Search HEMATOPOIETIC+STEM+CELLS | Search HEMATOPOIETIC+STEM+CELLS |
7 | INSERTIONAL MUTAGENESIS | 84743 | 2% | 14% | 46 | Search INSERTIONAL+MUTAGENESIS | Search INSERTIONAL+MUTAGENESIS |
8 | IN VIVO EXPANSION | 66142 | 0% | 100% | 5 | Search IN+VIVO+EXPANSION | Search IN+VIVO+EXPANSION |
9 | LAM PCR | 66142 | 0% | 100% | 5 | Search LAM+PCR | Search LAM+PCR |
10 | GENE TRANSFER | 57591 | 6% | 3% | 130 | Search GENE+TRANSFER | Search GENE+TRANSFER |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LAROCHELLE, A , DUNBAR, CE , (2013) HEMATOPOIETIC STEM CELL GENE THERAPY: ASSESSING THE RELEVANCE OF PRECLINICAL MODELS.SEMINARS IN HEMATOLOGY. VOL. 50. ISSUE 2. P. 101-130 | 166 | 58% | 3 |
2 | BUDAK-ALPDOGAN, T , BANERJEE, D , BERTINO, JR , (2005) HEMATOPOIETIC STEM CELL GENE THERAPY WITH DRUG RESISTANCE GENES: AN UPDATE.CANCER GENE THERAPY. VOL. 12. ISSUE 11. P. 849 -863 | 139 | 70% | 22 |
3 | MERTEN, OW , HEBBEN, M , BOVOLENTA, C , (2016) PRODUCTION OF LENTIVIRAL VECTORS.MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT. VOL. 3. ISSUE . P. - | 77 | 79% | 3 |
4 | SAKUMA, T , BARRY, MA , IKEDA, Y , (2012) LENTIVIRAL VECTORS: BASIC TO TRANSLATIONAL.BIOCHEMICAL JOURNAL. VOL. 443. ISSUE . P. 603-618 | 116 | 52% | 75 |
5 | SCHAMBACH, A , ZYCHLINSKI, D , EHRNSTROEM, B , BAUM, C , (2013) BIOSAFETY FEATURES OF LENTIVIRAL VECTORS.HUMAN GENE THERAPY. VOL. 24. ISSUE 2. P. 132-142 | 73 | 68% | 36 |
6 | CHANG, AH , SADELAIN, M , (2007) THE GENETIC ENGINEERING OF HEMATOPOIETIC STEM CELLS: THE RISE OF LENTIVIRAL VECTORS, THE CONUNDRUM OF THE LTR, AND THE PROMISE OF LINEAGE-RESTRICTED VECTORS.MOLECULAR THERAPY. VOL. 15. ISSUE 3. P. 445 -456 | 118 | 53% | 45 |
7 | MATRAI, J , CHUAH, MKL , VANDENDRIESSCHE, T , (2010) RECENT ADVANCES IN LENTIVIRAL VECTOR DEVELOPMENT AND APPLICATIONS.MOLECULAR THERAPY. VOL. 18. ISSUE 3. P. 477-490 | 88 | 54% | 121 |
8 | NIENHUIS, AW , PERSONS, DA , (2012) DEVELOPMENT OF GENE THERAPY FOR THALASSEMIA.COLD SPRING HARBOR PERSPECTIVES IN MEDICINE. VOL. 2. ISSUE 11. P. - | 90 | 65% | 3 |
9 | COCKRELL, AS , KAFRI, T , (2007) GENE DELIVERY BY LENTIVIRUS VECTORS.MOLECULAR BIOTECHNOLOGY. VOL. 36. ISSUE 3. P. 184 -204 | 99 | 51% | 143 |
10 | ANSORGE, S , HENRY, O , KAMEN, A , (2010) RECENT PROGRESS IN LENTIVIRAL VECTOR MASS PRODUCTION.BIOCHEMICAL ENGINEERING JOURNAL. VOL. 48. ISSUE 3. P. 362-377 | 94 | 59% | 5 |
Classes with closest relation at Level 1 |